AbbVie said on Monday its treatment for a group of blood cancers failed to meet the main goal of significantly improving the ...

A programme to evaluate a blood test for early signs of pancreatic cancer has started to recruit volunteers. The Safe-D study ...

‘Three years earlier provides time for intervention,’ the lead researcher says of the early detection test. Mr. Curl covered ...

“These results demonstrate that it is possible to detect circulating tumor DNA more than three years prior to clinical ...

A Johns Hopkins University study shows that a simple blood test may detect cancer long before symptoms emerge, potentially ...

AbbVie (ABBV) stock in focus after a Phase 3 trial setback for leukemia therapy venetoclax marketed with Roche (RHHBY) in ...

Researchers at Johns Hopkins University have discovered that cancer can be detected in the bloodstream a full three years ...

Driven, athletic, and a role model to his community, 20-year-old Eddie Kaufman has been fighting an aggressive form of blood ...

A new hereditary condition has been discovered that affects patients' ability to repair DNA – leaving them both at greater ...

The AbbVie-Roche cancer drug venetoclax failed to meet its primary endpoint in a phase 3 trial to treat newly diagnosed ...

England's National Health Service said Friday it is the first health system in the world to offer a targeted blood cancer ...

This 'Forgotten' Blood Test Can Catch Cancer Early first appeared on Parade on Jun 15, 2025 This story was originally ...